Dr Daniel Sister shares PRP knowledge at BACN meeting
Aesthetic manufacturer Croma-Pharma partnered with the British Association of Cosmetic Nurses (BACN) at their regional meeting.
Aesthetic manufacturer Croma-Pharma partnered with the British Association of Cosmetic Nurses (BACN) at their regional meeting.
As of January 25, aesthetic manufacturer Croma-Pharma has confirmed completion of the decentralised procedure for its new botulinum toxin.
Aesthetic manufacturer Croma-Pharma will be sponsoring the Aesthetics Award for Reception Team of the Year.
Aesthetic manufacturer Croma-Pharma has added the Anchor Plus PDO threads to its product offering
Aesthetic manufacturer Croma-Pharma has expanded its face mask range.
CCR unveiled its first ever trend report on the aesthetic specialty at an exclusive press event at the conference on October 14 focusing on future trends and innovations in aesthetics.
Aesthetics reports on the highlights from the 19th Aesthetic & Anti-Aging Medicine World Congress
Aesthetic manufacturer Croma-Pharma has launched a new polynucleotide based injectable named juvenus.
Aesthetics manufacturer Croma-Pharma has entered a licensing agreement with dermatology company Crescita Therapeutics for the rights to Pliaglis.
Biopharmaceutical company Hugel America and aesthetic manufacturer Croma-Pharma has unveiled that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for letibotulinumtoxinA as a treatment for glabellar lines.